Frontiers in Oncology (Apr 2024)
Commentary: Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases
Abstract
No abstracts available.Keywords
Frontiers in Oncology (Apr 2024)